Lifestyle program for pemphigus: quality of life
Part of Immune system & allergy, Skin clinical trials.
This study tests whether a program focused on diet and exercise can improve quality of life for people with pemphigus, a rare skin condition that causes blisters. If you're willing to try lifestyle changes, this trial may help you feel better and manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with pemphigus (a rare blistering skin condition).
- You are willing and able to follow a diet and exercise plan as part of the study.
- You do not have any serious health problems that would make it hard to follow the program.
- You are not pregnant or currently breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called CM313 for people with moderate to severe pemphigus, a blistering skin condition. It's for patients who haven't had this treatment before and may have not responded well to other therapies.
This study compares a tailored “maintenance” treatment plan to the usual standard care in adults with newly diagnosed pemphigus (PV or PF). It aims to see whether the personalized approach can help control the disease while reducing the burden of long-term treatment.
This study is for adults with certain autoimmune blistering skin conditions. Researchers want to better understand and test treatments that could improve symptoms and healing for people with these specific diseases.
This study tests whether a steroid mouthwash and/or light therapy (photobiomodulation) can help heal painful mouth sores caused by pemphigus vulgaris, an autoimmune disease that damages the inside of the mouth and skin.
This study looks at how Pemphigus Vulgaris (a rare blistering skin condition) affects gum health. Researchers will check your teeth and gums to see if the disease is linked to gum problems.
This study tests a new drug, CM313, for people with moderate to severe pemphigus (a blistering skin disease). It aims to see if the drug can help heal the blisters and sores.
Hear when a new Pemphigus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.